You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

b cell repertoire

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T and B Cell Repertoire Changes in Response to Orencia® in

Recruiting
  • Rheumatoid Arthritis
    • New York, New York
      Hospital for Special Surgery
    Mar 13, 2023

    B- and T-cell Repertoire and Immune Response in Acute and

    Recruiting
    • COVID-19
      • Washington, District of Columbia
      • +3 more
      Jan 24, 2023

      COVID, SARS-CoV 2, Corona Virus Infection Trial in Antwerp

      Recruiting
      • COVID
      • +4 more
        • Antwerp, Belgium
          Universitairy hospital of Antwerp
        Apr 4, 2022

        Venous Ulcer, Sickle Cell Ulcer, Diabetic Ulcer Trial in Paris (Saliva sampling, Blood sampling, Interviews)

        Not yet recruiting
        • Venous Ulcer
        • +3 more
        • Saliva sampling
        • +3 more
        • Paris, Ile De France, France
          Dermatology unit - Cochin Hospital - APHP
        Sep 8, 2023

        T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy

        Not yet recruiting
        • Non-small Cell Lung Cancer Metastatic
          • (no location specified)
          Sep 13, 2023

          Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor Trial in Durham (Abemaciclib,

          Recruiting
          • Metastatic Breast Cancer
          • +2 more
          • Durham, North Carolina
            Duke University Medical Center
          Jun 7, 2022

          Circulating Tumor DNA and T Cell Repertoire Predict

          Not yet recruiting
          • Carcinoma, Non-Small-Cell Lung
          • Brain Metastases
          • Whole-brain radiotherapy
          • Wuhan, Hubei, China
            Union hospital
          Feb 12, 2023

          ALLoreactive T-Cell receptOr RePertoire in kidnEy

          Recruiting
          • Renal Transplant Rejection
          • +3 more
          • Mixed lymphocyte reaction
          • Vienna, Austria
            Medical university of Vienna
          Apr 5, 2022

          T-cell Repertoire in Acute Myeloid Leukemia Undergoing Donor

          Recruiting
          • Acute Myeloid Leukemia
          • Biospecimen Collection
          • Laboratory Biomarker Analysis
          • Los Angeles, California
            USC / Norris Comprehensive Cancer Center
          Nov 16, 2021

          Will Permit Sites to Proactively Assess TAA, HLA and HPV-16

          Terminated
          • Head and Neck Cancer
          • +7 more
          • Tumor Profiling
          • Scottsdale, Arizona
          • +2 more
          Dec 2, 2022

          B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

          Recruiting
          • B-cell Acute Lymphoblastic Leukemia
          • +2 more
          • CD19/CD22-bispecific CAR-T cells
          • Beijing, Beijing, China
            Liang Wang
          Oct 7, 2023

          B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

          Recruiting
          • B-Cell Lymphoblastic Leukemia
          • Acute Lymphoblastic Leukemia
          • Tampa, Florida
            Moffitt Cancer Center
          Nov 28, 2023

          Recurrent DLBCL, Refractory Diffuse Large B-cell Lymphoma Trial in Tianjin (RC19D2 cell injection)

          Recruiting
          • Recurrent Diffuse Large B-Cell Lymphoma
          • Refractory Diffuse Large B-cell Lymphoma
          • RC19D2 cell injection
          • Tianjin, Tianjin, China
            Hematology Hospital of the Chinese Academy of Medical Sciences
          Sep 14, 2023

          High-Dose Methotrexate Clearance in Diffuse Large B-Cell

          Recruiting
          • Central Nervous System Lymphoma
          • Diffuse Large B-Cell Lymphoma
          • Non-Interventional Study
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          Sep 8, 2023

          B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

          Recruiting
          • B-cell Acute Lymphoblastic Leukemia
          • QH103 Cell Injection
          • +2 more
          • Hefei, Anhui, China
            Anhui Provincial Hospital
          Sep 21, 2023

          Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

          Recruiting
          • Diffuse Large B-cell Lymphoma Recurrent
          • Diffuse Large B Cell Lymphoma Refractory
          • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
          • Hangzhou, Zhejiang, China
            Zhejiang Cancer Hospital
          Oct 12, 2023

          Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

          Not yet recruiting
          • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
          • +5 more
          • Boston, Massachusetts
          • +1 more
          Jun 28, 2023

          Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

          Not yet recruiting
          • Lymphoma, B-Cell
          • +6 more
          • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
          • Guayaquil, Guayas, Ecuador
            Instituto Oncológico Nacional Dr. Juan Tanca Marengo
          Apr 27, 2023

          Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

          Not yet recruiting
          • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
          • (no location specified)
          Sep 5, 2023

          Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

          Not yet recruiting
          • Hematopoietic Stem Cell Transplantation
          • Hematologic Malignancy
          • CliniMACS®
          • (no location specified)
          Oct 17, 2023

          Large B-cell Lymphoma Trial (Glofitamab, Polatuzumab vedotin, Obinutuzumab)

          Not yet recruiting
          • Large B-cell Lymphoma
          • (no location specified)
          Oct 3, 2023

          Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

          Not yet recruiting
          • Follicular Lymphoma
          • +3 more
          • Tazemetostat Pill
          • New York, New York
            Weill Cornell Medicine/NewYork-Presbyterian Hospital
          Jun 28, 2023

          Relapsed or Refractory Diffuse Large B-cell Lymphoma Trial in Beijing (BEBT-908 for injection)

          Active, not recruiting
          • Relapsed or Refractory Diffuse Large B-cell Lymphoma
          • BEBT-908 for injection
          • Beijing, China
            Cancer Hospital Chinese Academy of Medical Sciences
          Oct 8, 2023

          B-cell Non-Hodgkin's Lymphoma Trial (SHR-A1912; R-Chemo)

          Not yet recruiting
          • B-cell Non-Hodgkin's Lymphoma
          • SHR-A1912; R-Chemo
          • (no location specified)
          Oct 23, 2023

          Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))

          Not yet recruiting
          • Lymphoma, B-Cell
          • +7 more
          • Adaptive Bridging Radiation Therapy (ABRT)
          • Boston, Massachusetts
            Dana-Farber Cancer Institute
          Aug 16, 2023